Skip to content

Cerivastatin

Baycol (cerivastatin) is a small molecule pharmaceutical. Cerivastatin was first approved as Baycol on 1997-06-26. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. The pharmaceutical is active against 3-hydroxy-3-methylglutaryl-Coenzyme A reductase.
Trade Name Baycol
Common Name Cerivastatin
Indication coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
Drug Class Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)
Cerivastatin
Get full access now